VenaFlux Solutions for Thrombosis assay : How does it work?
Quantify cell adhesion, rolling, migration, cell-cell adhesion, platelet aggregation, thrombi formation - all under shear flow
top of page
Cellix Technical Team
Feb 20, 20233 min read
VenaFlux for thrombosis: Installation and training guide
Thrombosis | Inflammation | Atherosclerosis | Engineered microcapillaries | Automated highthroughput flow assay for shear stress experiment
52
Cellix Technical Team
Feb 14, 20234 min read
Interference of C604 on platelet aggregation pathways
Platelet adhesion and aggregation under flow | C604 alters the cell's major biophysical properties | Set the shear rate to model thrombosis
79
Cellix Technical Team
Jan 23, 20233 min read
Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel
Test the effect of HE-NECA and cangrelor on thrombi formation | Platelet Activation and Thrombus Formation In Vitro |
28
Cellix Technical Team
Jan 16, 20235 min read
Cardiovascular: Platelets - Thrombosis Adhesion Assay
Novel microflow system | Low flow rates (5 pL min-1 to 10 μL min-1) and shear stress levels
85
Cellix Technical Team
Jan 9, 20233 min read
Cellix's VenaFlux Solutions mimic human blood vessels
Quantify cell adhesion, rolling, migration, cell-cell adhesion, platelet aggregation, thrombi ormation - all under shear flow.
181
Cellix Technical Team
Nov 22, 20223 min read
A role for SHARPIN in platelet linear protein ubiquitination and function – By Moore et al. (2021).
Role of SHARPIN in regulating platelet function | Perfusing whole blood | Accumulation on collagen | Reduced linear ubiquitination
217
Cellix Technical Team
Nov 14, 20228 min read
Cardiovascular: Atherosclerosis Monocyte Adhesion - chemokines -oxidised LDL
Role of different stimuli recognised to play an important part in atherosclerosis development | Leukocyte adhesion to endothelial cells |
172
Cellix Technical Team
Oct 10, 20223 min read
P-selectin targeting polysaccharide-based nano-gels for miRNA delivery
Targeting assays | fluorescence microscopy | miRNA-based therapeutics in atherothrombotic diseases
185
Cellix Technical Team
Jan 24, 20224 min read
Nanovesicles dissolve blood clots reducing side-effects
How does the nanovesicle work | Thrombus selectivity under physiological flow conditions | Targeted thrombolysis under flow conditions |
306
bottom of page